Welcome to LookChem.com Sign In|Join Free
  • or
2-[2-(methoxymethoxy)-4-methylphenyl]ethanol is a chemical with a specific purpose. Lookchem provides you with multiple data and supplier information of this chemical.

219736-05-7

Post Buying Request

219736-05-7 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

219736-05-7 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 219736-05-7 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 2,1,9,7,3 and 6 respectively; the second part has 2 digits, 0 and 5 respectively.
Calculate Digit Verification of CAS Registry Number 219736-05:
(8*2)+(7*1)+(6*9)+(5*7)+(4*3)+(3*6)+(2*0)+(1*5)=147
147 % 10 = 7
So 219736-05-7 is a valid CAS Registry Number.

219736-05-7Relevant academic research and scientific papers

Total Synthesis of a Dimeric Thymol Derivative Isolated from Arnica sachalinensis

De Silvestro, Irene,Drew, Samuel L.,Nichol, Gary S.,Duarte, Fernanda,Lawrence, Andrew L.

, p. 6813 - 6817 (2017)

The total synthesis of a dimeric thymol derivative (thymarnicol) isolated from Arnica sachalinensis was accomplished in 6 steps. A key biomimetic Diels–Alder dimerization was found to occur at ambient temperature and the final oxidative cyclization occurs

Imidazopyridines for the treatment of neurological disorders

-

Example 5001, (2010/01/31)

Corticotropin releasing factor (CRF) antagonists of formula (I): and their use in treating psychiatric disorders and neurological diseases, anxiety-related disorders, post-traumatic stress disorder, supranuclear palsy and feeding disorders as well as treatment of immunological, cardiovascular or heart-related diseases and colonic hypersensitivity associated with psychopathological disturbance and stress in mammals.

Imidazopyrimidines and imidazopyridines for the treatment of neurological disorders

-

, (2008/06/13)

Corticotropin releasing factor (CRF) antagonists of formula (I): and their use in treating psychiatric disorders and neurological diseases, anxiety-related disorders, post-traumatic stress disorder, supranuclear palsy and feeding disorders as well as treatment of immunological, cardiovascular or heart-related diseases and colonic hypersensitivity associated with psychopathological disturbance and stress in mammals.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 219736-05-7